À Propos de l'Entreprise
- Raison sociale: Nanjing Hanxin Pharmaceutical Technology Co.,Ltd
- Pays d'enregistrement: China
- Adresse: Building C5, No.9 Weidi Road, Xianlin Street, Qixia District, Nanjing, Jiangsu, China
- Année de création: 2021
Description:
Nanjing Hanxin Pharmaceutical Technology Co., Ltd, established in 2017, manufactures active pharmaceutical ingredients, digestive-system drugs, and peptides. The company was recognized as a Jiangsu Provincial Technology-Advanced Service Enterprise in 2019, obtained national-level intellectual property management system certification in 2020, acquired Nanjing Cuccess Pharmaceutical Co., Ltd. and earned National High-tech Enterprise status in 2021, and was designated a Jiangsu Provincial Specialized, Refined, Differential, and Innovative SME in 2022. Offering CRO, CMO, and CDMO contract manufacturing with OEM, ODM, and own-brand production, the company distributes to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Activités Commerciales
Principes Actifs Pharmaceutiques (API)
Fabricant de Principes Actifs (API)Fabricant
Services de sous-traitance & d’externalisation
Organisation de Développement et Fabrication sous Contrat (CDMO)
Marchés de Vente
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Semaglutide, PDRN, Earthworm Protein, Chondroitin sulfate oligosaccharides (LetopCS) ® ）, GABA（ γ- Aminobutyric acid, Ergothione, Acetic acid ganerik (chemical synthesis), Acetylated sodium hyaluronate, Cationic sodium hyaluronate, Chloroacetyl catechol, DeGu insulin side chain, Epinephrine (chemical synthesis), Liraglutide 31 peptide main chain, Liraglutide (recombinant), NmHA ® Nano sodium hyaluronate, Norepinephrine bitartrate (chemically synthesized), Recombinant CPB, Recombinant EK, Recombinant Kex II, Recombinant type III collagen protein, Smegglutide 29 peptide main chain, Smegglutide side chain
- Extraits Naturels & Ingrédients Botaniques: Animal extracts
- Ingrédients Biologiques & de Fermentation: Biological fermentation raw materials
- Classification ATC (Anatomique, Thérapeutique, Chimique): Insulin Aspart
Nos Produits & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
FDA
GMP Formulation Facility
FDA- and GMP-compliant manufacturing site producing injectables
FDA inspections with zero Form 483 observations
FDA approval for oncology
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire